A carregar...
Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience
Background and Aims: Patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) who are dialysis-dependent form a unique group, in which safety, tolerability and efficacy of sofosbuvir (SOF)-based direct-acting antivirals (DAAs) need further evaluation. Methods: We performed a retros...
Na minha lista:
Publicado no: | J Clin Transl Hepatol |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
XIA & HE Publishing Inc.
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5411352/ https://ncbi.nlm.nih.gov/pubmed/28507922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00060 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|